TrialJournal of glaucoma2025
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study.
Makoto Aihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.